|
|
|
|
|
searchin this issue
premium serviceseventsdirectory servicesadvertisingcustomer care |
Archives :: Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Displaying 161 - 180 of 863 stories.
July 25, 2012
Lonza recorded a 3.1% fall in first-half profits compared with the year-ago period, to SF94 million ($94.5 million). First-half sales increased, however, by 64.6%, to SF1.96 billion...http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Lonza-Reports-Fall-in-First-Half-Profits_45170.html July 24, 2012
NOVASEP EXPANDS HPAPI MANUFACTURING FACILITY IN FRANCE Novasep (Pompey, France) says it will expand its highly potent active pharmaceutical ingredients (HPAPIs) manufacturing...http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/PharmaFine-Chemicals-Roundup-July-24_45140.html July 19, 2012
Novasep (Pompey, France) says it will expand its highly potent active pharmaceutical ingredients (HPAPI) manufacturing capabilities at the company's Le Mans, France facility. The...http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Novasep-Expands-Its-HPAPI-Manufacturing-Facility-in-France_45009.html July 17, 2012
DSM’s pharmaceutical division has signed its first contract manufacturing agreement in South America, the company says. Under the agreement, DSM with work with Recepta Bioopharma...http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/DSM-Signs-Contract-Manufacturing-Deal-in-Brazil_44939.html July 17, 2012
Foster Wheeler says that one of its global engineering and construction group subsidiaries has been awarded an engineering, procurement, and construction management (EPCM) services...http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Foster-Wheeler-Receives-Contract-for-API-Plant-Conversion-in-the-U-K-_44933.html July 16, 2012
President Obama has signed into law a measure that will revise FDA’s ability to oversee certain provisions related to pharmaceutical ingredients and includes a generic drug...http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/U-S-Enacts-Bill-Creating-Generic-Drug-User-Fee-Program_44918.html July 10, 2012
Mylan (Canonsburg, PA) says it applauds President Barack Obama’s signing of the Food and Drug Administration Safety and Innovation Act, legislation that will significantly...http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Mylan-Welcomes-FDA-Safety-and-Innovation-Act_44793.html July 10, 2012
OBAMA SIGNS OFF ON FDA GENERIC DRUG USER FEE ACT - Lindsay Frost President Obama has signed into law a measure that will revise FDA’s ability to oversee certain provisions...http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/PharmaFine-Chemicals-Roundup-July-10_44794.html July 10, 2012
Lonza says it has launched the new GS Xceed gene expression system—the latest generation of Lonza’s GS System, which has been used to create more than 100 cell lines and 13...http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Lonza-Launches-New-GS-Gene-Expression-System_44786.html July 9, 2012
President Obama has signed into law a measure that will revise FDA’s ability to oversee certain provisions related to pharmaceutical ingredients and includes a generic drug...http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Obama-Signs-Off-on-FDA-Generic-Drug-User-Fee-Act_44782.html July 5, 2012
Siegfried (Zofingen, Switzerland), a producer of active pharmaceutical ingredients (APIs), intermediates, and finished drugs, says it will build a new production facility at Nantong...http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Siegfried-to-Build-Pharma-Ingredients-Plant-in-China_44646.html July 3, 2012
ALBEMARLE EXPANDS API PRODUCTION SITE Albemarle says it has expanded and upgraded its U.S. FDA-approved multi-product active pharmaceutical ingredient (API) manufacturing facility at...http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/PharmaFine-Chemicals-Roundup-July-3_44619.html July 3, 2012
Active pharmaceutical ingredient (API) manufacturer ScinoPharm Taiwan (Shanhua, Taiwan) says it will invest NT$1.13 billion ($38 million) to build a high potency cytotoxic injectable...http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/ScinoPharm-Invests-in-High-Potency-Facility_44612.html July 2, 2012
Bristol-Myers Squibb (BMS; New York) and biopharmaceutical company Amylin Pharmaceuticals (San Diego, CA) say that BMS will acquire Amylin for $31/share in cash, pursuant to a cash...http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Bristol-Myers-Squibb-to-Acquire-Amylin-Pharmaceuticals-for-$5-3-Billion_44588.html June 27, 2012
Albemarle says it has expanded and upgraded its U.S. FDA-approved multi-product active pharmaceutical ingredient (API) manufacturing facility at South Haven, MI. Production using the...http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Albemarle-Expands-API-Production-Site_44502.html June 26, 2012
HOVIONE REPORTS RISE IN SALES Active pharmaceutical ingredients (API) manufacturer Hovione (Loures, Portugal) has recorded a 24% rise in sales in the fiscal year ended March 31, 2012...http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/PharmaFine-Chemicals-Roundup-June-26_44484.html June 22, 2012
Active pharmaceutical ingredients (API) manufacturer Hovione (Loures, Portugal) has recorded a 24% rise in sales in the fiscal year ended March 31, 2012, compared with the previous...http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Hovione-Reports-Rise-in-Sales_44423.html June 21, 2012
DSM Pharmaceutical Products (Parsippany, NJ), the business unit of DSM which provides contract manufacturing and development services to the pharma and biopharmaceutical industries...http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/DSM-Signs-Manufacturing-Agreement-with-Major-Pharma-Company_44358.html June 19, 2012
FDA ISSUES CLOSE OUT LETTER TO AKZONOBEL’S API PLANT IN MEXICO The U.S. Food and Drug Administration (FDA) issued a close-out letter on June 11, to Akzo Nobel Chemicals’...http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/PharmaFine-Chemicals-Roundup-June-19_44289.html June 12, 2012
PFIZER TO CUT 177 JOBS AT IRELAND API PLANTS Pfizer plans to cut 177 jobs at the company’s two active pharmaceutical ingredient (API) manufacturing plants at Cork, Ireland. The...http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/PharmaFine-Chemicals-Roundup-June-12_44106.html |
|
Connect with IHS Chemical Week |
Quick links |
Our related sites |
|
contact us | about us |
customer care |
privacy policy |
sitemap |
advertise
|
Follow us on Twitter
